600+ sources. One page. See who else covered it.
Coverage for hundreds of thousands of Arkansas Medicaid enrollees next year is in question after the Trump administration refused to renew a key state waiver. The state might not be the last to have to adjust to an arcane rule change under the One Big Beautiful Bill Act.
We haven't written up this one. KFF Health News has the full story — the link below goes straight to it.
Pfizer and the French-Swiss firm Valneva say trials have shown a 70% efficacy rate in people aged five and above.
Pfizer and the French-Swiss firm Valneva say trials have shown a 70% efficacy rate in people aged five and above.
Last year's funding cuts to federal agencies that oversee foodborne illness outbreaks are being tested with the record cyclosporiasis outbreak in the U.S.
Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State.
Dr. Derek Ebner told Newsweek not all warning signs of colorectal cancer begin where you'd expect.